AstraZeneca PLC (ZEGA) — Cash Flow Reinvestment Rate
AstraZeneca PLC (ZEGA) has a Cash Flow Reinvestment Rate of 0.73x as of September 2025, reinvesting €3.73 Billion (capex €1.73 Billion plus investments €-2.00 Billion) from operating cash flow of €5.13 Billion. Check ZEGA cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
AstraZeneca PLC Cash Flow Reinvestment Rate (2014–2024)
Historical reinvestment intensity for AstraZeneca PLC across 11 annual periods. Explore ZEGA strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for AstraZeneca PLC (2014–2024)
Year-by-year capital reinvestment analysis for AstraZeneca PLC. For live market cap and broader valuation context, see AstraZeneca PLC (ZEGA) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.06x | €12.57 Billion | €11.86 Billion | €4.59 Billion | ▲ +65.8% |
| 2023 | 0.64x | €6.62 Billion | €10.36 Billion | €3.39 Billion | ▲ +407.9% |
| 2022 | 0.13x | €1.23 Billion | €9.81 Billion | €1.09 Billion | ▼ -55.8% |
| 2021 | 0.28x | €1.70 Billion | €5.96 Billion | €1.09 Billion | ▼ -53.9% |
| 2020 | 0.62x | €2.96 Billion | €4.80 Billion | €961.00 Million | ▲ +65.9% |
| 2019 | 0.37x | €1.10 Billion | €2.97 Billion | €979.00 Million | ▼ -17.7% |
| 2018 | 0.45x | €1.18 Billion | €2.62 Billion | €1.04 Billion | ▼ -8.8% |
| 2017 | 0.50x | €1.77 Billion | €3.58 Billion | €1.33 Billion | ▼ -67.3% |
| 2016 | 1.52x | €6.28 Billion | €4.14 Billion | €2.31 Billion | ▲ +214.5% |
| 2015 | 0.48x | €1.60 Billion | €3.32 Billion | €1.33 Billion | ▲ +204.0% |
| 2014 | 0.16x | €1.12 Billion | €7.06 Billion | €1.01 Billion | — |